Hexokinase II (HK2) is a key enzyme involved in glucose metabolism, catalyzing the phosphorylation of glucose to glucose-6-phosphate.
HK2 is highly expressed in tissues with high glucose demand, such as the brain and cancer cells, and plays a crucial role in regulating energy production and cellular growth.
Discover how PubCompare.ai, the AI-driven platform, can optimize your Hexokinse II research.
Locate the best protocols from literature, pre-prints, and patents using our advanced search and comparison tools.
Improve reproducibility and accuracy with our AI-driven analysis that identifies the most effective methods and products.
Streamline your Hexokinase II studies with PubCompare.ai - the ultimate resource for enhancing your research.
Hexokinase II Homo sapiens Institutional Animal Care and Use Committees Internal Ribosome Entry Sites Malignant Neoplasms Mice, Laboratory Mouse mammary tumor virus
Glucose consumption was evaluated by measuring supernatant concentration using a double beam spectrophotometer (UNICAM UV2, Analytical S.n.c., PR, Italy), by the hexokinase (HK) and glucose 6 phosphate dehydrogenase (G6PD) coupling system, following the reduction of NADP at 340 nm. The assay medium contained 100 mM Tris HCl, pH 7.4, 2 mM ATP, 10 mM NADP, 2 mM MgCl2, 2 IU of HK and 2 IU of G6PD. The reaction was started after the addition of 5 μl of cell medium.
Colla R., Izzotti A., De Ciucis C., Fenoglio D., Ravera S., Speciale A., Ricciarelli R., Furfaro A.L., Pulliero A., Passalacqua M., Traverso N., Pronzato M.A., Domenicotti C, & Marengo B. (2016). Glutathione-mediated antioxidant response and aerobic metabolism: two crucial factors involved in determining the multi-drug resistance of high-risk neuroblastoma. Oncotarget, 7(43), 70715-70737.
Cell lysates from H460, A549, H1975, and HCC827 cells were prepared 24 h after treatment with DMSO, Milciclib (1 or 10 μM), THZ1 (10 μM), or LDC4297 (10 μM); 16 h after treatment with 1× PBS or Deferoxamine (100 μM); or 72 h after transfection with shRNA or an overexpression plasmid. Uncropped immunoblots are presented in Supplementary Fig. 29. The following antibodies were used: HIF-1α (Novus Biologicals; NB100-105; 1:1000 dilution), GLUT1 (Millipore Sigma; 07-1401; 1:500 dilution), GLUT3 (Abcam; ab15311; 1:1000 dilution), Hexokinase 1 (Cell Signaling; C35C4; 1:1000 dilution), Hexokinase 2 (Cell Signaling; C64G5; 1:1000 dilution), CDK2 (Cell Signaling; 78B2; 1:1000 dilution), CDK4 (Cell Signaling; D9G3E; 1:1000 dilution), CDK7 (Cell Signaling; MO1; 1:1000 dilution), TRKA (Cell Signaling; 12G8; 1:1000 dilution), PIK3CA (Cell Signaling; C73F8; 1:1000 dilution), PTEN (Cell Signaling; 9559; 1:1000 dilution), Phospho-T170 CDK7 (Abcam; ab155976; 1:1000 dilution), Rpb1 NTD (Cell Signaling; D8L4Y; 1:1000 dilution), Phospho-S5 Rpb1 (Cell Signaling; D9N5I; 1:1000 dilution), PKCι (BD Biosciences; Clone 23; 1:1000 dilution), TXNIP (Cell Signaling; D5F3E; 1:1000 dilution), and Beta Actin (Imgenex; IMG-5142; 1:1000 dilution). Immunoblots were analyzed using an Odyssey Imaging System (LI-COR).
Ghezzi C., Wong A., Chen B.Y., Ribalet B., Damoiseaux R, & Clark P.M. (2019). A high-throughput screen identifies that CDK7 activates glucose consumption in lung cancer cells. Nature Communications, 10, 5444.
Western blots were performed as previously described on freshly isolated hearts (i.e. separate from the perfused hearts) [11 (link),18 (link)]. Briefly, fifty micrograms of total protein extract from mouse heart tissue was separated electrophoretically and transferred to PVDF membrane. The membranes were probed with the following antibodies: pyruvate kinase M2 isoform (PKM2, #4053), lactate dehydrogenase A (LDHA, #2012), acetyl-CoA carboxylase (ACC, #3662), phospho-acetyl-CoA carboxylase, (p-ACC, Ser 79, #3661), and pyruvate dehydrogenase (PDH, #2784) were purchased from Cell Signaling Technology, Inc. (Danvers, MA); hexokinase II (HXKII, sc-6521), glutamine-fructose-6-phosphate transaminase 2 (GFAT2, sc-134710), O-GlcNAcase (OGA, sc-135093) and peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α, sc-13067) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA); O-GlcNAc transferase (OGT, O6264) from Sigma-Aldrich Corp. (St. Louis, MO); phospho- pyruvate dehydrogenase (p-PDH, Ser293, #ABS204) was purchased from EMD Millipore Corporation (Billerica, MA);malonyl CoA-carboxylase (MCD, 15265-1-AP) was purchased from Proteintech (Chicago, IL); glucose transporter 4 (Glut4, GTX88031) was purchased from GeneTex (Irvine, CA). Muscle carnitine palmitoyltransferase 1 (M-CPT1) and pyruvate dehydrogenase kinase (PDK)2 and PDK4 were obtained as a personal gift from Gebre Woldegiorgis (Oregon Health Sciences University, Beaverton, OR) and Robert Harris (Indiana University School of Medicine, Indianapolis, IN). Total protein O-GlcNAc levels were determined using an antibody (RL-2) from Abcam (Cambridge, MA) on freshly isolated protein. Western blots were visualized with enhanced chemiluminescence upon exposure to Kodak BioMax Light ML-1 film. Membranes were stripped by washing for 30 min with 100 mM dithiothreitol, 2% (wt/vol) SDS, 62.5 mM Tris·HCl, pH 6.7, at 70°C, followed by three 10-min washes with TBS for additional antibody analysis. Immunoblots of proteins without a phosphorylated form were normalized to total protein staining in the molecular weight region around the band of interest by Thermo Scientific Pierce Reversible Protein Stain Kit for PVDF Membranes (Thermo Scientific, Rockford, IL), which are shown. Phosphorylated proteins were normalized to their appropriate total protein.
Ledee D., Smith L., Bruce M., Kajimoto M., Isern N., Portman M.A, & Olson A.K. (2015). c-Myc Alters Substrate Utilization and O-GlcNAc Protein Posttranslational Modifications without Altering Cardiac Function during Early Aortic Constriction. PLoS ONE, 10(8), e0135262.
Single-stranded AAV vectors were produced by triple transfection of human embryonic kidney 293 cells and purified by a CsCl-based gradient method (27 (link)). Transgenes used were:
Enhanced green fluorescent protein (GFP) driven by 1) the cytomegalovirus (CMV) early enhancer/chicken beta actin (CAG) promoter; 2) the CAG promoter with the addition of four tandem repeats of the mirT122a sequence (5′CAAACACCATTGTCACACTCCA3′), the mirT1 sequence (5′TTACATACTTCTTTACATTCCA3′) or both, cloned in the 3′ untranslated region of the expression cassette; 3) the short version of the adipocyte protein 2 (mini/aP2) promoter (28 (link),29 (link)); or 4) the short version of the uncoupling protein-1 (mini/UCP1) promoter (30 (link),31 (link));
Hexokinase 2 (HK2) driven by 1) the CMV promoter, 2) the mini/aP2 promoter, or 3) the mini/UCP1 promoter;
Placental-derived secreted alkaline phosphatase (SeAP) driven by the mini/aP2 promoter;
Vascular endothelial growth factor (VEGF)-164 driven by the mini/UCP1 promoter; and
Red fluorescent protein (RFP), driven by the CMV promoter.
A noncoding plasmid carrying the CMV promoter, the mini/aP2 promoter, or the mini/UCP1 promoter and a multicloning site was used to produce null particles.
Jimenez V., Muñoz S., Casana E., Mallol C., Elias I., Jambrina C., Ribera A., Ferre T., Franckhauser S, & Bosch F. (2013). In Vivo Adeno-Associated Viral Vector–Mediated Genetic Engineering of White and Brown Adipose Tissue in Adult Mice. Diabetes, 62(12), 4012-4022.
Adipocytes Alkaline Phosphatase beta-Actin Brown Adipose Tissue Uncoupling Protein Cells cesium chloride Chickens Cloning Vectors Cytomegalovirus Embryo enhanced green fluorescent protein Hexokinase II Homo sapiens Kidney Placenta Plasmids Proteins Repetitive Region Transfection Transgenes UCP1 protein, human Untranslated Regions Vascular Endothelial Growth Factors
Immunohistochemistry and immunoblot analysis were performed as previously described (48 (link)). In the current study, blots were incubated with LDHA (1:1,000), LDHB (1:1,000), hexokinase 1 (1:1,000), hexokinase 2 (1:1,000), Aldolase C (1:1,000), cone arrestin (1:1,000), pPKM2 (1:1,000), PKM2 (1:1,000), PKM1 (1:1,000), Pde6β (1:1,000), rhodopsin (1:1,000), rod arrestin (1:1,000), M-opsin (1:1,000), PDH (1:1,000) and actin (1:1,000) antibodies (Table S5) overnight at 4° C. The blots were then washed and incubated with HRP-coupled anti-mouse or anti-rabbit secondary antibodies (as appropriate) for 60 min at room temperature. After washing, blots were developed with enhanced SuperSignal West Dura Extended Duration Substrate (Thermo Fisher Scientific, Waltham, MA) and visualized using a Kodak Imager with chemiluminescence capability.
Rajala A., Bhat M.A., Teel K., Gopinadhan Nair G.K., Purcell L, & Rajala R.V. (2023). The function of lactate dehydrogenase A in retinal neurons: implications to retinal degenerative diseases. PNAS Nexus, 2(3), pgad038.
Polyclonal LDHA, LDHB, and aldolase C antibodies were purchased from Proteintech (Rosemount, IL). Rabbit polyclonal red/green cone opsin (M-opsin), S-opsin, cone arrestin, actin, and rabbit and mouse secondary antibodies were obtained from Millipore (Billerica, MA). Monoclonal 1D4 rhodopsin antibody was a kind gift from Dr. James F. McGinnis (University of Oklahoma Health Sciences Center). DAPI used for nuclear staining was procured from Invitrogen-Molecular Probes (Carlsbad, CA). Polyclonal pPKM2 (Y105), PKM2, PKM1, PDH, hexokinase 1, and hexokinase 2 antibodies were obtained from Cell Signaling (Danvers, MA). The monoclonal anti-arrestin antibody was a kind gift from Dr. Paul Hargrave (University of Florida, Gainesville). Polyclonal glial fibrillary acidic protein (GFAP) was purchased from Dako (Carpinteria, CA). Monoclonal GS antibody was purchased from Abcam (Cambridge, MA). The monoclonal Pde6β antibody was purchased from Santa Cruz Biotechnology (Dallas, TX).
Rajala A., Bhat M.A., Teel K., Gopinadhan Nair G.K., Purcell L, & Rajala R.V. (2023). The function of lactate dehydrogenase A in retinal neurons: implications to retinal degenerative diseases. PNAS Nexus, 2(3), pgad038.
The Pubchem database was used to acquire the SMILES of the ligands (c9-, t11-CLA, and BADGE). The 3D structure of the ligands was obtained through online tool of NCI/CADD group by uploading SMILES files of ligands. These files were used further for molecular docking analysis and interaction studies. The molecular docking of PPARγ protein (PDB ID: 3NOA) with the ligands (BADGE and 9, 11-CLA) and between 9, 11-CLA and hexokinase-II (hHK-II) (HK-II; PDB ID: 2nzt) was performed using AutoDock (4.0) based on the Lamarckian genetic algorithm (Hu and Shelver, 2003). The active site was defined using AutoGrid. The grid size was set to 90 × 90 × 90 points with a grid spacing of 0.375 Å, centred on the binding site of the protein molecules [12 (link)]. The grid box included the entire protein molecule to ensure enough space for the ligand translational and rotational walk. 50° for rotation and step sizes of 1 Å for translation were chosen. The maximum number of energy evaluations was set to 25,000,000, and 100 runs were performed for each ligand. The genetic algorithm was set to generate 27,000 operations on a single population of 200 individuals for each of the 100 independent runs. Default values were used for crossover, mutation, and elitism operator weights (0.80, 0.02, and 1.00, respectively). Docked conformations of 100 runs were clustered on the basis of their root mean square (RMS) deviation tolerance of the ligand conformation [13 (link)]. Consequently, the best docked conformation was selected and visualized using PyMOL 0.99. The best among top 10 binding was analysed for interaction using LigPlot, which elucidate 2D schematic representation of all the bonds formed during ligand and protein or receptor (amino acid residues) binding [14 (link)].
Dubey V., Mishra A.K, & Ghosh A.R. (2023). Appraisal of the Possible Role of PPARγ Upregulation by CLA of Probiotic Pediococcus pentosaceus GS4 in Colon Cancer Mitigation. PPAR Research, 2023, 9458308.
Measurements of non-structural carbohydrate (NSC) were performed on 1 cm2 leaf discs, collected from leaf lamina with a cork borer, and immediately frozen in liquid nitrogen. Soluble carbohydrates were extracted at 80 °C for 45 min, after grinding the leaf discs in a glass-glass homogeniser, containing 1.5 mL of 80% (v/v) ethanol, 20% (v/v) 100 mM Hepes (pH 7.1), and 10 mM MgCl2. After centrifugation at 16,000× g for 5 min, the supernatant was analysed for soluble carbohydrate content. Glucose, fructose, and sucrose were determined by an enzymatic coupled spectrophotometric assay with hexokinase (1.2 U), glucose phosphate dehydrogenase (0.3 U), phosphoglucose isomerase (0.3 U), and acid invertase (30 U) as described in Moscatello et al. [43 (link)]. Starch was quantified from the pellet remaining after extraction of soluble sugars, after three washing with 50 mM NaAcetate buffer (pH 4.5), suspended in 1 mL of the same buffer, and autoclaved at 120 °C for 45 min. The suspension was incubated at 50 °C for 1 h with amyloglucosidase (40 U) and α-amylase (4 U). The glucose produced by starch hydrolysis was determined enzymatically as described above.
Proietti S., Paradiso R., Moscatello S., Saccardo F, & Battistelli A. (2023). Light Intensity Affects the Assimilation Rate and Carbohydrates Partitioning in Spinach Grown in a Controlled Environment. Plants, 12(4), 804.
Western blotting analysis was applied to examine protein levels using antibodies recognizing Rho A (Abcam, Cambridge, MA, USA), ROCK1 (Abcam), ROCK2 (Abcam), myosin phosphatase-targeting subunit 1 (MYPT1) (Cell Signaling Technology (CST), Danvers, MA, USA), phosphorylated (p)-MYPT1 (CST), glucose transporter type 1, erythrocyte/brain (GLUT1) (Abcam), hexokinase 2 (HK2) (Abcam), pyruvate dehydrogenase kinase 1(PDK1) (Abcam), phosphofructokinase 1 (PFK1) (CST), lactate dehydrogenase A (LDHA) (Abcam), osteopontin (OPN) (Abcam), RUNX2 (Abcam), AMPK (Abcam), p-AMPK (Abcam), ubiquitination (Proteintech, Rosemont, IL, USA), Sodium Potassium ATPase (Abcam), and β-actin (Proteintech). Human aortic valve tissues and VICs were rinsed with cold 1× PBS, and then lysed on ice in radioimmunoprecipitation assay (RIPA) lysis buffer (Beyotime Biotech; 50 mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 1 mM sodium orthovanadate, 1 mM sodium fluoride, 1 mM Ethylenediaminetetraacetic acid (EDTA), and leupeptin) containing 1 mM phenylmethylsulfonyl fluoride (PMSF) for 15 min, followed by homogenization with 20 kHz ultrasonic lapping and centrifugation at 14,000 rpm at 4 °C in a refrigerated microcentrifuge for 15 min to extract total protein. Then, supernatants were stored and a bicinchoninic acid (BCA) Protein Assay Kit (Beyotime Biotech) was used to detect the total protein concentration to normalize the samples. Equal amounts of samples (30–45 μg/lane) were run on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels and then transferred to polyvinylidene difluoride (PVDF) membranes using a wet-transfer system. The membranes were blocked using QuickBlock Blocking Buffer (Beyotime Biotech) at room temperature for 20 min, and then incubated with primary antibodies at 4 °C overnight. After three washes with Tris-buffered saline-Tween-20 (TBST) (Servicebio, Wuhan, China), we incubated membranes with the corresponding secondary antibodies coupled with horseradish peroxidase (HRP) for 90 min on shakers. After three washes with TBST, enhanced chemiluminescence (ECL) signals (Amersham Biosciences, Piscataway, NJ, USA) were detected using an ECL kit (Millipore, Billerica, MA, USA) with Imaging system (Thermo Fisher Scientific). Densitometric quantification was performed using Image J software.
Liu H., Yin H., Wang Z., Yuan Q., Xu F., Chen Y, & Li C. (2023). Rho A/ROCK1 signaling-mediated metabolic reprogramming of valvular interstitial cells toward Warburg effect accelerates aortic valve calcification via AMPK/RUNX2 axis. Cell Death & Disease, 14(2), 108.
Hexokinase II is a lab equipment product from Cell Signaling Technology. It is an enzyme that catalyzes the phosphorylation of glucose to glucose-6-phosphate, which is the first step in glycolysis.
Ab209847 is a lab equipment product. It serves as a core component for various laboratory applications. The detailed specifications and intended use of this product are not available for inclusion in an unbiased and factual description.
Sourced in United States, Germany, China, United Kingdom, Morocco, Ireland, France, Italy, Japan, Canada, Spain, Switzerland, New Zealand, India, Hong Kong, Sao Tome and Principe, Sweden, Netherlands, Australia, Belgium, Austria
PVDF membranes are a type of laboratory equipment used for a variety of applications. They are made from polyvinylidene fluoride (PVDF), a durable and chemically resistant material. PVDF membranes are known for their high mechanical strength, thermal stability, and resistance to a wide range of chemicals. They are commonly used in various filtration, separation, and analysis processes in scientific and research settings.
Sourced in United States, China, Japan, Germany, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Netherlands, Belgium, Lithuania, Denmark, Singapore, New Zealand, India, Brazil, Argentina, Sweden, Norway, Austria, Poland, Finland, Israel, Hong Kong, Cameroon, Sao Tome and Principe, Macao, Taiwan, Province of China, Thailand
TRIzol reagent is a monophasic solution of phenol, guanidine isothiocyanate, and other proprietary components designed for the isolation of total RNA, DNA, and proteins from a variety of biological samples. The reagent maintains the integrity of the RNA while disrupting cells and dissolving cell components.
Ab115730 is a laboratory product offered by Abcam. It is a specific reagent, but without additional details, a concise and unbiased description cannot be provided while maintaining objectivity. The core function of this product is not available.
Sourced in China, United States, Switzerland, Germany, Japan, United Kingdom
RIPA lysis buffer is a detergent-based buffer solution designed for the extraction and solubilization of proteins from cells and tissues. It contains a mixture of ionic and non-ionic detergents that disrupt cell membranes and solubilize cellular proteins. The buffer also includes additional components that help to maintain the stability and activity of the extracted proteins.
Sourced in United States, United Kingdom, China, Germany, Japan, Canada, Morocco, Sweden, Netherlands, Switzerland, Italy, Belgium, Australia, France, India, Ireland
β-actin is a cytoskeletal protein that is ubiquitously expressed in eukaryotic cells. It is an important component of the microfilament system and is involved in various cellular processes such as cell motility, structure, and integrity.
Hexokinase 1 is an enzyme that catalyzes the conversion of glucose to glucose-6-phosphate, which is the first step in glycolysis. It plays a key role in cellular glucose metabolism.
Hexokinase II (HK2) is a key enzyme involved in glucose metabolism, catalyzing the phosphorylation of glucose to glucose-6-phosphate. HK2 is highly expressed in tissues with high glucose demand, such as the brain and cancer cells, and plays a crucial role in regulating energy production and cellular growth. Understanding the function and regulation of HK2 is important for research in areas like neurometabolism, cancer metabolism, and diabetes.
While there are four main isozymes of hexokinase (HK I-IV), Hexokinase II is the predominant isoform expressed in tissues with high glucose demand, such as the brain and cancer cells. The HK2 enzyme can exist in different conformational states and oligomeric forms, which can affect its kinetic properties and regulation. Researchers may need to consider these variations when studying Hexokiase II in specific biological contexts.
PubCompare.ai allows researchers to screen protocol literature more efficiently and leverage AI to pinpoint critical insights. The platform can help identify the most effective protocols related to Hexokinase II for your specific research goals. PubCompare.ai's AI-driven analysis can highlight key differences in protocol effectiveness, enabling you to choose the best option for reproducibility and accuracy in your Hexokinase II studies. This can streamline your research and improve the quality of your findings.
One challange with studying Hexokinase II is its complex regulation, which can involve allosteric modulation, phosphorylation, and translocation. Researchers may need to carefully optimize assay conditions and consider the cellular context to accurately measure HK2 activity. Additionally, Hexokinase II is highly expressed in cancer cells, making it important to differentiate its role in normal versus tumor metabolism. PubCompares.ai can help navigate these usage challenges by providing insights from the latest research protocols.
PubCompare.ai's advanced search and comparison tools can help researchers efficiently locate the best protocols for studying Hexokinase II from the literature, preprints, and patents. The platform's AI-driven analysis can identify the most effective methods and products, enabling you to choose the optimal approach for your Hexokinase II research. By improving reproducibility and accuracy, PubCompare.ai can streamline your studies and enhance the quality of your findings on this important metabolic enzyme.
More about "Hexokinase II"
Hexokinase II (HK2) is a crucial enzyme involved in glucose metabolism, catalyzing the conversion of glucose to glucose-6-phosphate.
This isoform of hexokinase is highly expressed in tissues with high energy demands, such as the brain and cancer cells, playing a vital role in regulating energy production and cellular growth.
Hexokinase 1 (HK1) is another closely related enzyme that shares similar functions in glucose metabolism.
HK2 is a widely studied target in various fields, including cancer biology, neuroscience, and metabolic disorders.
Researchers often utilize techniques like Western blotting, immunohistochemistry, and activity assays to investigate the expression and function of HK2.
Common antibodies used in these studies include Ab209847, Ab227198, and Ab205718.
To ensure accurate and reproducible results, researchers may employ PVDF membranes, TRIzol reagent, and RIPA lysis buffer in their experimental protocols.
Additionally, the use of housekeeping genes, such as β-actin, can help normalize HK2 expression data.
PubCompare.ai, an AI-driven platform, can optimize Hexokinase II research by providing access to the best protocols from literature, preprints, and patents.
The advanced search and comparison tools on the platform can help researchers identify the most effective methods and products, improving the reproducibility and accuracy of their HK2 studies.
Streamlining the research process, PubCompare.ai can be the ultimate resource for enhancing Hexokinase II investigations.